Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
11:38am, Tuesday, 25'th Jul 2023
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
05:55pm, Monday, 24'th Jul 2023
Growth investors are frequently looking for biotech stocks to buy. So what exactly is a biotech stock?
Better Big Biotech Buy: Vertex vs. Biogen
10:09am, Monday, 24'th Jul 2023
Vertex Pharmaceuticals is heading for a big moment -- a regulatory decision on a potential new blockbuster. Biogen recently won regulatory approval for a drug that may become its new growth driver.
Drug Stock Vertex May See Boost From Non-Opioid Painkillers, Says Analyst
03:24pm, Friday, 21'st Jul 2023
Leerink Partners analyst David Risinger raised his price target to $442 from $396. His new target indicates a 20% upside from the recent price of $365.
My Take: 4 Strong Growth Stocks to Buy This Week
07:15am, Thursday, 20'th Jul 2023
Eli Lilly's emphasis on diabetes and obesity drugs sets it apart. Royal Caribbean is benefiting as people return to travel experiences.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
08:15am, Wednesday, 19'th Jul 2023
Vertex dominates the cystic fibrosis market and is dipping its toes in new areas. Moderna's mRNA vaccine platform could lead to major approvals in the coming years.
2 Monster Stocks to Buy Without Any Hesitation
05:30am, Monday, 17'th Jul 2023
These two companies -- giants in the worlds of biotech and pharma -- have a great earnings track record. And they both may be about to enter a new era of growth.
Vertex Pharmaceuticals: Buy at the High?
05:30am, Friday, 14'th Jul 2023
Vertex shares have advanced almost 20% since the start of the year. Investors are optimistic about Vertex's prospects in its specialty area of cystic fibrosis and beyond.
3 Pharma Stocks That AI is Loving in July
09:24pm, Thursday, 13'th Jul 2023
When it comes to investing in pharmaceutical stocks, an intriguing area for future growth is gene editing. This is an exciting field that may provide a solution to some of our most vexing diseases, su
3 Top Biotech Stocks Defying the Bear Market
07:45am, Thursday, 13'th Jul 2023
Vertex Pharmaceuticals' strong pipeline is positioning the company for the future. Viking Therapeutics' stock is soaring as the market anticipates its candidate drugs hitting the marketplace.
3 Biotech Stocks to Buy for Long-Term Gains
07:01am, Thursday, 13'th Jul 2023
Suppose you're looking for a sector that will benefit from an end to the Federal Reserve's interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with long-dated
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
05:50am, Thursday, 13'th Jul 2023
Axsome Therapeutics' current drugs and pipeline programs look especially promising. Brookfield Renewable could double in six years if it hits the low end of its projected growth range.
Is Now the Right Time to Embrace Biotech ETFs?
12:34pm, Wednesday, 12'th Jul 2023
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.
3 Biotech Stocks That AI is Loving in July
07:51am, Wednesday, 12'th Jul 2023
Artificial intelligence (AI) has become an invaluable tool for investors seeking opportunities in the stock market. Its ability to analyze large amounts of data and recognize patterns makes it an ally
3 Things About Vertex Pharmaceuticals That Smart Investors Know
06:00am, Wednesday, 12'th Jul 2023
Vertex Pharmaceuticals may be about to show it can expand beyond its billion-dollar specialty area. The company is waiting for a regulatory decision on its blood disorders candidate -- but this may on
